Skip to main content
TipRanks
Go Ultimate75% OFF

Gregory Went Insider Profile

4 Followers

Gregory Went, former CEO, Director at Adamas Pharmaceuticals, holds 431.78K shares in Adamas Pharmaceuticals (Ticker: ADMS).

Gregory Went's Trading History

ADMS
Adamas Pharmaceuticals
Apr 10, 2019―Uninformative Buy―$3.55M
ADMS
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Apr 10, 2019Uninformative Buy$0.0056,250$0.00―
Mar 21, 2019Uninformative Sell$50.49K6,319$7.99―
Nov 08, 2018Informative Buy$49.93K3,850$12.97-56.60%
Mar 22, 2018Uninformative Sell$116.93K4,541$25.75―
Mar 09, 2018Uninformative Buy$0.0020,625$0.00―

You May Also Like

Gregory Went insider profile FAQ

What is the percentage of profitable transactions made by Gregory Went?
The percentage of profitable transactions made by Gregory Went is 75%.
What is the average return per transaction made by Gregory Went?
The average return per transaction made by Gregory Went is -2.00%.
What stocks does Gregory Went hold?
Gregory Went holds: ADMS stocks.
What was Gregory Went's most profitable transaction?
Gregory Went’s most profitable transaction was an Informative Sell of ADMS stock on March 19, 2015. The return on the trade was 29.70%.
What is Gregory Went's role in Adamas Pharmaceuticals?
Gregory Went's role in Adamas Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.